Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Lilly and Amylin reach agreement to terminate diabetes alliance

Nov. 9, 2011

LivTech and Yakult Honsha enter option agreement for LIV-2008 anticancer program

Nov. 9, 2011

Daiichi Sankyo gains Brazilian rights to drug for overactive bladder

Nov. 8, 2011

Pfizer returns worldwide rights to TNF-alpha-targeted Nanobodies

Nov. 7, 2011

XTL Biopharmaceuticals set to acquire technology being developed for cartilage-related diseases

Nov. 7, 2011

Atlab Pharma and BZL Biologics enter licensing agreement for [177Lu]-J591

Nov. 4, 2011

BMS and Aslan enter agreement for anticancer compound

Nov. 4, 2011

ExonHit extends strategic collaboration with Allergan

Nov. 3, 2011

Furiex acquires exclusive license to develop MuDelta

Nov. 3, 2011

AgonOx and MedImmune join to develop TNF receptor superfamily member 4 agonists

Nov. 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...